Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016
Year: 2019
Type: article
Abstract: Objective: The aim of this study was to investigate the in vitro antimicrobial susceptibilities of clinically important Gram-negative bacteria from seven intensive care units in Taiwan in 2016. Materials and methods: In total, 300 non-duplicate isolates of Escherichia coli (n=100), Klebsiella pneumoniae (n=100), and Pseudomonas aeruginosa (n=100) collected from 300 patients were studied. The minimum inhibitory concentrations (MICs) of these isolates to antimicrobial agents were determined using the broth microdilution method. Carbapenemase-encoding genes ( bla KPC , bla NDM , bla IMP , bla VIM , and bla OXA-48-like ) were studied for the isolates that were not susceptible to any carbapenems. Sequencing analysis of the mcr genes ( mcr -1–5) was conducted for all isolates with colistin MICs ≥4 mg/L. Results: Ertapenem non-susceptibility was detected in 3% (n=3) E. coli and 12% (n=12) K. pneumoniae isolates. The susceptibility rates of imipenem, ceftazidime–avibactam (CAZ–AVB), and ceftolozane–tazobactam (CLZ–TAZ) were 99%, 99%, and 88%, respectively, for E. coli , 91%, 100%, and 80%, respectively, for K. pneumoniae , and 66%, 91%, and 93%, respectively, for P. aeruginosa . Carbapenemase-encoding genes were not detected in E. coli , were detected in four (33.3%) K. pneumoniae isolates that were not susceptible to ertapenem (three harboring bla KPC and one harboring bla OXA-48-like ), and were not detected in P. aeruginosa isolates that were not susceptible to imipenem. One K. pneumoniae isolate was resistant to colistin (MIC 4 mg/L) and negative for mcr genes. Conclusion: CAZ–AVB exhibited excellent activity against carbapenem-resistant Enterobacteriaceae , and CLZ–TAZ exhibited good activity against imipenem-resistant P. aeruginosa .
Source: Infection and Drug Resistance
DOI: 10.2147/idr.s193638
Institutions: Far Eastern Memorial Hospital, National Cheng Kung University Hospital, National Cheng Kung University, Chi Mei Medical Center, Chia Nan University of Pharmacy and Science, Kaohsiung Veterans General Hospital, National Yang Ming University, Taichung Veterans General Hospital, Kaohsiung Medical University, Kaohsiung Medical University Chung-Ho Memorial Hospital, Wan Fang Hospital, Taipei Medical University, National Taiwan University, National Taiwan University Hospital
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: ceftazidime-avibactam, ceftolozane/tazobactam, antimicrobial susceptibility, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, carbapenem resistance, carbapenemase genes, mcr genes, colistin resistance, ertapenem, imipenem, intensive care unit isolates, Taiwan, Gram-negative bacteria
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W2918521644
